Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hitoshi Shimizu is active.

Publication


Featured researches published by Hitoshi Shimizu.


Organic Process Research & Development | 2005

Industrial Synthesis of Maxacalcitol, the Antihyperparathyroidism and Antipsoriatic Vitamin D3 Analogue Exhibiting Low Calcemic Activity

Hitoshi Shimizu; Kazuki Shimizu; Noboru Kubodera; Tetsuhiro Mikami; Kaname Tsuzaki; Hiroyuki Suwa; Koji Harada; Akira Hiraide; Motoki Shimizu; Kaichiro Koyama; Yoshihide Ichikawa; Daisuke Hirasawa; Yasushi Kito; Mio Kobayashi; Masaharu Kigawa; Masahiro Kato; Toshiro Kozono; Hideki Tanaka; Makoto Tanabe; Masanori Iguchi; Mitsutaka Yoshida


Tetrahedron Letters | 2004

Efficient modification of steroid 20S-hydroxy functionality for industrial preparation of 1α,25-dihydroxy-22-oxavitamin D3, Maxacalcitol

Hitoshi Shimizu; Kazuki Shimizu; Noboru Kubodera; Kenichi Yakushijin; David A. Horne


Heterocycles | 2004

Regioselective Cleavage of Trisubstituted Epoxy-Linkage Using Lithium Trialkylborohydride Reagents: A New Route to the Key Intermediate of Maxacalcitol

Hitoshi Shimizu; Kazuki Shimizu; Noboru Kubodera; Kenichi Yakushijin; David Horne


Archive | 2001

Process for producing erythromycin derivative

Hitoshi Shimizu; Kaname Tsuzaki; Mitsuhiro Kurita


Archive | 2001

Erythromycin derivative having novel crystal structures and processes for their production

Akira Hiraide; Kaichiro Koyama; Hitoshi Shimizu; Kaname Tsuzaki


Journal of Synthetic Organic Chemistry Japan | 2009

Practical Synthesis of Maxacalcitol Based on Usefully Classical Reactions and Photolysis

Hitoshi Shimizu; Tetsuhiro Mikami; Masahiro Kato


Tetrahedron Letters | 2004

Synthesis of 21-nor-22-oxa-1α,25-dihydroxyvitamin D3 derivatives in quest of a drug with low calcemic activity

Hitoshi Shimizu; Kazuki Shimizu; Yasushi Uchiyama; Atsuko Sugita; Tetsuhiro Mikami; Tsuyoshi Yamauchi; Masahiro Kato; Kazumi Morikawa


Organic Process Research & Development | 2018

Development of a Kilogram-Scale Synthesis of a Novel Anti-HCV Agent, CH4930808

Tsuyoshi Haneishi; Yoshiaki Kato; Hiroshi Fukuda; Tomoyuki Shimamura; Takemi Tanokura; Akira Hiraide; Kaichiro Koyama; Masato Fudesaka; Kenji Maeda; Nobuyuki Nakata; Masahiro Nagase; Takahiko Yabuzaki; Hiroaki Takao; Masaharu Kigawa; Hitoshi Shimizu; Makoto Shimizu


Heterocycles | 2006

Total inversion of cis-C5 maxacalcitol into its trans-C5 isomer via the sulforene intermediate

Tsuyoshi Yamauchi; Koji Suzuki; Hitoshi Shimizu; Masahiro Kato


Archive | 2003

Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate

Kenji Kamada; Akira Hiraide; Kaichiro Koyama; Hitoshi Shimizu; Gary H. Ward; Vandana K. Cheruvallath; Stephan Parent

Collaboration


Dive into the Hitoshi Shimizu's collaboration.

Top Co-Authors

Avatar

Kazuki Shimizu

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Masahiro Kato

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kenji Maeda

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Masahiro Nagase

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Noboru Kubodera

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroshi Fukuda

National Institute of Radiological Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge